DO
FOLD

denkapparat Operations’s Amicus Therapeutics FOLD Stock Holding History

denkapparat Operations’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$316K Hold
21,856
– – 0.13% 268
2025
Q4 		$311K Hold
21,856
– – 0.17% 233
2025
Q3 		$172K Hold
21,856
– – 0.11% 272
2025
Q2 		$125K Hold
21,856
– – 0.1% 240
2025
Q1 		$178K Buy
21,856
+3,652
+20% +$33.8K 0.19% 209
2024
Q4 		$171K Buy
+18,204
New +$189K 0.25% 162

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

denkapparat Operations's FOLD Position: Q1 2026 in Review

denkapparat Operations held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 21,856 shares worth $316K. The position accounts for 0.13% of the portfolio, ranked #268.

denkapparat Operations first reported a position in FOLD in Q4 2024 and has held it in 6 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • denkapparat Operations held 21,856 shares of Amicus Therapeutics worth $316K as of Q1 2026.
  • denkapparat Operations left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up 0.13% of denkapparat Operations's portfolio in Q1 2026, its #268 holding.
  • denkapparat Operations first reported a position in Amicus Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on denkapparat Operations's 13F filing for Q1 2026, filed 11 May 2026.